Table 2 Treatment patterns within one year of osteoporosis diagnosis
|  | All patients (n = 10,292) | |
|---|---|---|
| Â | n | % |
No treatment | 7689 | 74.7 |
Bisphosphonates | 2422 | 23.5 |
 Alendronate | 1265 | 12.3 |
 Zoledronic acid | 720 | 7.0 |
 Risedronate | 312 | 3.0 |
 Ibandronate | 125 | 1.2 |
Non-bisphosphonates | 181 | 1.8 |
 Raloxifene | 97 | 0.9 |
 Strontium ranelate | 43 | 0.4 |
 Calcitonin | 41 | 0.4 |
 Teriparatide | 0 | 0.0 |
 Parathyroid hormone | 0 | 0.0 |
Mean time until treatment (days) | Mean | SD |
 Bisphosphonate initiation (n = 2422) | 48.9 | 81.2 |
 Non-bisphosphonate initiation (n = 181) | 40.8 | 78.4 |